External Source

Dr. Flaherty On Resistance In Braf-mutant Melanoma

2016 1:11
Synopsis
Keith T. Flaherty, MD, director of Developmental Therapeutics at the Cancer Center of Massachusetts General Hospital, discusses ...

You Might Also Like

Dr. Flaherty on Second-Line Therapy for BRAF-Mutant Melanoma 1:42
Dr. Flaherty On Second-line Therapy For Braf-mutant Melanoma
2019
Dr. Flaherty Discusses BRAF Inhibitors in Melanoma 1:57
Dr. Flaherty Discusses Braf Inhibitors In Melanoma
2018
Dr. Flaherty Discusses the COLUMBUS Trial in Melanoma 1:51
Dr. Flaherty Discusses The Columbus Trial In Melanoma
2018
Dr. Flaherty on the Rationale to Explore Triplet Therapy in BRAF V600E-Mutant Melanoma 1:32
Dr. Flaherty On The Rationale To Explore Triplet Therapy In ...
2019
Dr. Keith T. Flaherty on the NEMO Trial in NRAS-Mutant Melanoma 2:30
Dr. Keith T. Flaherty On The Nemo Trial In Nras-mutant Melan...
2016
Dr. Flaherty on the COLUMBUS Trial Updates in Melanoma 2:26
Dr. Flaherty On The Columbus Trial Updates In Melanoma
2019
Dr. Flaherty on the Tolerability of Encorafenib/Binimetinib in Melanoma 1:02
Dr. Flaherty On The Tolerability Of Encorafenib/binimetinib ...
2018
Drug Combination in Melanoma is More Better by Keith Flaherty, MD 29:25
Drug Combination In Melanoma Is More Better By Keith Flahert...
2012
Case 2: Frontline Decisions in Stage IV BRAF-mutant Melanoma 8:13
Case 2: Frontline Decisions In Stage Iv Braf-mutant Melanoma
2017
Dr. Ryan Sullivan on Treating BRAF-Mutant Patients With Melanoma 1:06
Dr. Ryan Sullivan On Treating Braf-mutant Patients With Mela...
2016
Dr. Keith Flaherty Discusses Long-Term Data from the COLUMBUS Trial 1:28
Dr. Keith Flaherty Discusses Long-term Data From The Columbu...
2016
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.